Rucaparib
CO-338-014
Phase 3 small_molecule completed
Quick answer
Rucaparib for Ovarian Cancer is a Phase 3 program (small_molecule) at pharmaand GmbH with 1 ClinicalTrials.gov record(s).
Program details
- Company
- pharmaand GmbH
- Indication
- Ovarian Cancer
- Phase
- Phase 3
- Modality
- small_molecule
- Status
- completed